When the Going Gets Tough: Treating Chronic Idiopathic Constipation: A Clinical Forum

Program Overview

The goal of this activity is to explore the pathophysiology of chronic idiopathic constipation (CIC), discuss key data on prescription CIC therapies, and debate crucial questions in the development and personalization of treatment plans for patients with CIC.

Credit Expired
CE Credit Expired
Expires: September 30, 2021

Target Audience

This activity was developed for physicians and other healthcare professionals treating patients with chronic idiopathic constipation (CIC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the underlying pathophysiology of chronic idiopathic constipation (CIC)
  • Apply key data on the benefits and risks of available therapies for the treatment of CIC
  • Develop evidence-based treatment plans with clear goals and coordinated care for individuals with CIC

Activity Faculty


Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE (Chair)

Dan and Lillie Sterling Professor of Gastroenterology
Chief, Gastroenterology, Hepatology, and Nutrition Division
Director, Gastrointestinal Physiology Laboratory
Memorial Hermann Hospital, Texas Medical Center
University of Texas Health Science Center at Houston
McGovern Medical School
Houston, TX


Darren M. Brenner, MD, FACG, AGAF

Associate Professor, Medicine and Surgery
Irene D. Pritzker Foundation Research Scholar
Director, Northwestern Neurogastromotility and Functional Bowel Programs
Director, Motts Tonelli GI Physiology Laboratory
Northwestern University – Feinberg School of Medicine
Chicago, IL


Lucinda A. Harris, MS, MD

Associate Professor, Medicine
Consultant, Division of Gastroenterology & Hepatology
Department of Medicine
Mayo Clinic
Scottsdale, AZ

Supporter Statement

Provider Statement

Disclosure of Financial Relationships


Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources